Answer
No data exist on ipilimumab use in pregnant women; animal studies show reproductive toxicity, human IgG1 crosses the placenta, fetal risk is unknown, and Yervoy is not recommended during pregnancy or in women of childbearing potential without effective contraception unless clinical benefit outweighs potential risk.
Sources for this answer
- YERVOY 5 mg/ml concentrate for solution for infusionBristol Myers Squibb Pharmaceuticals limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 47Document updated
Sources checked